Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -274.57% is 59% above its 5-year average of -672.16%, near the high end of its 5-year range (-982900.00%–42.02%).
95.25% above its 12-month average of -5781.41%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -25827.14%.
OPERATING MARGIN
-274.57%
OPERATING MARGIN AVG TTM
-5781.41%
OPERATING MARGIN AVG 3Y
-762.31%
OPERATING MARGIN AVG 5Y
-672.16%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+95.25%
CURRENT VS 3Y AVG
+63.98%
CURRENT VS 5Y AVG
+59.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
13.86%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-2081.74%
vs the sector median at left
Beam Therapeutics Inc.
Market Cap
$2.51B
Operating Margin
-274.57%
TTM Avg
-5781.41%
3Y Avg
-762.31%
5Y Avg
-672.16%
Market Cap
$2.74B
Operating Margin
12.21%
TTM Avg
13.21%
3Y Avg
-4.78%
5Y Avg
-42.05%
Market Cap
$2.14B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$1.73B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.72B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$1.00B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
Market Cap
$472.39M
Operating Margin
-8.63%
TTM Avg
-11.52%
3Y Avg
-18.04%
5Y Avg
-16.64%
Market Cap
$397.55M
Operating Margin
-58.53%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | $2.51B | -274.57% | -5781.41% | -762.31% | -672.16% |
| TransMedics Group, Inc. (TMDX)vs › | $2.74B | 12.21% | 13.21% | -4.78% | -42.05% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.14B | -867.87% | -840.98% | -774.76% | -1234.34% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 11.69% | -8.16% | -10.59% | -4.68% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.72B | -651.67% | -787.38% | -968.58% | -820.03% |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -6.98% | -25.06% | -156.73% | -114.38% |
| NeoGenomics, Inc. (NEO)vs › | $472.39M | -8.63% | -11.52% | -18.04% | -16.64% |
| NRC Health (NRC)vs › | $459.30M | 10.53% | 20.52% | 24.67% | 27.45% |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | -58.53% | -50.96% | -52.76% | -52.76% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.03M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
84.0%
Operating Margin
-274.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -25827.14% |
| 2026-03-31 | -337.81% |
| 2025-12-31 | -15.29% |
| 2025-09-30 | -1307.60% |
| 2025-06-30 | -1419.22% |
| 2025-03-31 | -1596.87% |
| 2024-12-31 | -332.71% |
| 2024-09-30 | -746.40% |
| 2024-06-30 | -891.06% |
| 2024-03-31 | -1405.29% |
| 2023-12-31 | 42.02% |
| 2023-09-30 | -629.72% |
| 2023-06-30 | -507.79% |
| 2023-03-31 | -408.66% |
| 2022-12-31 | -444.10% |
| 2022-09-30 | -577.90% |
| 2022-06-30 | -492.23% |
| 2022-03-31 | -904.00% |
| 2021-12-31 | -124.31% |
| 2021-09-30 | -9126.34% |
| 2021-06-30 | -982900.00% |
| 2021-03-31 | -3339550.00% |
| 2020-12-31 | -679983.33% |
| 2020-09-30 | -622016.67% |
| 2020-06-30 | -438083.33% |
| 2020-03-31 | -472583.33% |
| 2019-12-31 | -439516.67% |
| 2019-09-30 | -300400.00% |
| 2019-06-30 | -294183.33% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
